on INNATE PHARMA (EPA:IPH)
Innate Pharma Announces Conference Call on its Portfolio and Finances
Innate Pharma, a biotechnology company, is holding a conference call on November 5, 2026. The call will be used to present the progress of its portfolio and its financial situation for the third quarter of 2026. The call is scheduled for 2:00 PM CET, 8:00 AM ET.
Key speakers will include Jonathan Dickinson, Chief Executive Officer, and Frédéric Lombard, Chief Financial Officer. The public can watch the event live and access a replay on the Innate Pharma website for 90 days.
Innate Pharma, listed on Euronext Paris and Nasdaq, develops immunotherapies targeting significant unmet medical needs. Its portfolio includes the drug IPH4502, as well as collaborations with Sobi and AstraZeneca.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news